Available Technologies

No technologies match these criteria. Please broaden your search criteria and try again.

Find technologies available for licensing from UC Davis.

Mesenchymal Stem Cell Derived Exosomes for Treating Peripheral Artery Disease

Researchers at the University of California, Davis have developed a method to isolate exosomes from mesenchymal stem cells that contain signaling molecules that induce angiogenesis. The isolated exosomes can be used for treating peripheral arterial disease.

Synthesis Technique to Achieve High-Anisotropy FeNi

Researchers at the University of California, Davis have developed an innovative synthesis approach to achieve high anisotropy L1 FeNi by combining physical vapor deposition and a high speed rapid thermal annealing (RTA).

Production of Glycolipid PEFAs from Yeasts

Method of using basidiomycetous yeasts to convert carbohydrates to glycolipid biosurfactants 

Enhanced Method of Geomasking Builds Upon Donut Method Using Demographic Information

Researchers at the University of California, Davis have developed an enhanced geomasking method building upon the current “Donut Method” which considers demographic information when masking medical-related geographic data. In doing this, greater medical validity is preserved and greater research utility is acquired, all without substantial loss in anonymity.

Wearable Monitoring System Better Understands Autism Spectrum Disorder

Researchers at the University of California, Davis have developed a wearable monitoring system to better understand the emotional dysregulation that an individual with an autism spectrum disorder (ASD) may encounter.

Cross-Layer Robust Header Compression (ROHC) Compressor Design

Researchers at the University of California, Davis have developed a ROHC compressor that adaptively adjusts the compression level based on an underlying Partially Observable Markov Decision Process (POMDP) model.

Upregulation of Cancer Suppressing MircoRNAs Through Short Chain Fatty Acids

Researchers at the University of California, Davis have discovered that the up-regulation of cancer suppressing microRNAs, such as miR-22, can be induced by bacterially generated-short chain fatty acids, retinoic acid and bile acid.

Novel Ethylene Conversion Method using E. coli to Convert Ethylene into Useful Chemicals

Researchers at the University of California, Davis have developed a biosynthesis pathway of ethylene glycol from ethylene in the industrial host Escherichia coli using a two-step process: 1) from ethylene to ethylene oxide, and 2) from the ethylene oxide to ethylene glycol.